This is a highly speculative micro-cap with a $331M market cap trading at an extreme 147.1x sales despite generating negative earnings and a deeply negative EPS of -80.6. There is no P/E, no forward P/E, and no PEG, which immediately removes traditional valuation anchors and signals a business with no proven earnings base. The operating margin of -11.60% and ROIC of -13.20% confirm capital destruction, not value creation. The only statistical comfort is an exceptionally high Altman Z-Score of 57.8 and a very strong current ratio of 25.7, implying near-term balance sheet safety. This is not a mispriced compounder — it is a balance-sheet-safe but operationally weak enterprise priced aggressively relative to sales with no demonstrated profitability.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.